Gene · 710
NIH grants1,786
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,786
Download this page as JSON| Grant | Title | SERPING1 papers | Newest fiscal year |
|---|---|---|---|
| U01AA020926 | 2/11 Spatially Resolved, Single Cell, Neuroimmune Transcriptomes in Alcohol Dependence | 1 | 2025 |
| U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 1 | 2025 |
| U01CA176726 | Life Course Cancer Epidemiology Cohort in Women | 1 | 2025 |
| U01CA200462 | MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm | 1 | 2025 |
| U01CA261842 | Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance | 1 | 2025 |
| U01CA274154 | Fibroblast orchestration of the immune response in pancreatic cancer | 1 | 2025 |
| U01DK108314 | Cedars Sinai Center for the Chronic Pancreatitis Clinical Research Consortium | 1 | 2025 |
| U01DK128847 | Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY) | 1 | 2025 |
| U01HL145386 | Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research | 1 | 2025 |
| U01HL145435 | Long Term Follow up of the Lung Transplant Outcomes Group Cohort | 1 | 2025 |
| U01HL146201 | Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | 1 | 2025 |
| U19AG023122 | Longevity Consortium | 1 | 2025 |
| U19AI057266 | Vaccine and Infection Induced Immunity in the Young and Aged | 1 | 2025 |
| U19AI089992 | Immune signatures of vaccine responses in vulnerable populations | 1 | 2025 |
| U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 1 | 2025 |
| U19AI128949 | Human anti-viral immune responses in tissues and circulation | 1 | 2025 |
| U19AI135972 | SARS-CoV adaptations through a Systems Biology Lens (SYBIL) | 1 | 2025 |
| U19AI142733 | Modulation of Lung Immune Responses to Viral Infection | 1 | 2025 |
| U19AI168632 | Early life respiratory viral infections shape immune development trajectories | 1 | 2025 |
| U19AI168643 | Immune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthma | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/grants?page=15